BRIEF published on 03/16/2026 at 09:40, 7 months 16 days ago JP Morgan Chase reduces its stake in Inventiva Actions Participation Crossing Thresholds JP Morgan Inventiva
BRIEF published on 03/12/2026 at 15:56, 7 months 20 days ago Threshold Crossing at Inventiva Actions Stock Market Crossing Thresholds JP Morgan Chase & Co. Inventiva
BRIEF published on 02/17/2026 at 14:32, 8 months 12 days ago Threshold Crossing by Deep Track Biotechnology Voting Rights Actions Threshold Crossing Inventiva Deep Track
BRIEF published on 02/17/2026 at 08:35, 8 months 12 days ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
BRIEF published on 02/17/2026 at 08:35, 8 months 12 days ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
PRESS RELEASE published on 02/17/2026 at 08:30, 8 months 12 days ago Inventiva reports preliminary 2025¹ fiscal year financial results Inventiva reports preliminary 2025 fiscal year financial results, showing €99.3 million in cash, €131.6 million in short-term deposits, and €4.5 million in revenues Revenues Financial Results Clinical-stage Inventiva Cash Equivalents
BRIEF published on 02/04/2026 at 22:05, 8 months 25 days ago Inventiva at the Guggenheim Biotech Summit 2026 New York Inventiva MASH Lanifibranor Biotech Summit
BRIEF published on 02/04/2026 at 22:05, 8 months 25 days ago Inventiva to Participate in Guggenheim Biotech Summit 2026 Biopharmaceuticals Inventiva MASH Lanifibranor Biotech Summit
PRESS RELEASE published on 02/04/2026 at 22:00, 8 months 25 days ago Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Inventiva to present at Guggenheim Emerging Outlook: Biotech Summit 2026. CEO Andrew Obenshain to participate in fireside chat on February 11, 2026, in New York City Fireside Chat Inventiva Biotech Summit Guggenheim Emerging Outlook CEO Andrew Obenshain
BRIEF published on 01/30/2026 at 11:21, 9 months 2 days ago JP Morgan Chase & Co.'s reduced stake in INVENTIVA Shares Threshold Crossing Right To Vote JP Morgan Inventiva
Published on 10/30/2026 at 23:35, 2 days 7 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 7 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 11 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 15 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 06:00, 42 minutes ago Wujiang Marks 90 Years Since Fei Xiaotong's Jiangcun Field Study
Published on 11/01/2026 at 10:35, 20 hours 7 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 1 day 1 hour ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 14 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 7 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 2 days 7 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 12 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 18 hours ago Capital increase through exercise of subscription rights
